Literature DB >> 26534739

Adjuvant chemotherapy in stage IB non-small cell lung carcinoma: A survival analysis.

D Coutinho1, A Gonçalves2, A Antunes2, S Campainha2, J Miranda3, A Barroso2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26534739     DOI： 10.1016/j.rppnen.2015.09.005

Source DB:  PubMed          Journal:  Rev Port Pneumol (2006)        ISSN： 0873-2159


× No keyword cloud information.
  3 in total

1.  Analysis of the clinicopathologic characteristics and prognostic of stage I invasive mucinous adenocarcinoma.

Authors:  Jizhuang Luo; Rui Wang; Baohui Han; Jie Zhang; Heng Zhao; Wentao Fang; Qingquan Luo; Jun Yang; Yunhai Yang; Lei Zhu; Tianxiang Chen; Xinghua Cheng; Qingyuan Huang; Yiyang Wang; Jiajie Zheng; Haiquan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2016-06-24       Impact factor: 4.553

2.  Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.

Authors:  Jizhuang Luo; Qingyuan Huang; Rui Wang; Baohui Han; Jie Zhang; Heng Zhao; Wentao Fang; Qingquan Luo; Jun Yang; Yunhai Yang; Lei Zhu; Tianxiang Chen; Xinghua Cheng; Yiyang Wang; Jiajie Zheng; Han Wu; Weicong Xia; Haiquan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-05       Impact factor: 4.553

3.  Prognosis of early stage pulmonary mucinous adenocarcinoma with different treatments.

Authors:  Jinyuan Liu; Shijiang Zhang; Jinhua Luo
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.